BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11943260)

  • 1. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study.
    Wiley JS; Dao-Ung LP; Gu BJ; Sluyter R; Shemon AN; Li C; Taper J; Gallo J; Manoharan A
    Lancet; 2002 Mar; 359(9312):1114-9. PubMed ID: 11943260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
    Thunberg U; Tobin G; Johnson A; Söderberg O; Padyukov L; Hultdin M; Klareskog L; Enblad G; Sundström C; Roos G; Rosenquist R
    Lancet; 2002 Dec; 360(9349):1935-9. PubMed ID: 12493261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Eur J Haematol; 2004 Apr; 72(4):259-63. PubMed ID: 15089763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12.
    Zhang LY; Ibbotson RE; Orchard JA; Gardiner AC; Seear RV; Chase AJ; Oscier DG; Cross NC
    Leukemia; 2003 Nov; 17(11):2097-100. PubMed ID: 12931211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia.
    Sellick GS; Rudd M; Eve P; Allinson R; Matutes E; Catovsky D; Houlston RS
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1065-7. PubMed ID: 15184265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P2X7 receptor of CLL lymphocytes-a molecule with a split personality.
    Di Virgilio F; Wiley JS
    Lancet; 2002 Dec; 360(9349):1898-9. PubMed ID: 12493250
    [No Abstract]   [Full Text] [Related]  

  • 7. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.
    Cabrini G; Falzoni S; Forchap SL; Pellegatti P; Balboni A; Agostini P; Cuneo A; Castoldi G; Baricordi OR; Di Virgilio F
    J Immunol; 2005 Jul; 175(1):82-9. PubMed ID: 15972634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia.
    Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Hoy T; Milligan D; Bentley P; Fegan C
    Br J Haematol; 2003 Oct; 123(1):66-71. PubMed ID: 14510944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rottlerin inhibits P2X(7) receptor-stimulated phospholipase D activity in chronic lymphocytic leukaemia B-lymphocytes.
    Shemon AN; Sluyter R; Wiley JS
    Immunol Cell Biol; 2007 Jan; 85(1):68-72. PubMed ID: 17130901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages.
    Shemon AN; Sluyter R; Fernando SL; Clarke AL; Dao-Ung LP; Skarratt KK; Saunders BM; Tan KS; Gu BJ; Fuller SJ; Britton WJ; Petrou S; Wiley JS
    J Biol Chem; 2006 Jan; 281(4):2079-86. PubMed ID: 16263709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages.
    Fernando SL; Saunders BM; Sluyter R; Skarratt KK; Wiley JS; Britton WJ
    J Infect Dis; 2005 Jul; 192(1):149-55. PubMed ID: 15942904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X7 polymorphism and chronic lymphocytic leukaemia.
    Mitsiades CS; Mitsiades N
    Lancet; 2003 Apr; 361(9367):1478; author reply 1478-9. PubMed ID: 12727428
    [No Abstract]   [Full Text] [Related]  

  • 13. In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
    Sturm I; Bosanquet AG; Hummel M; Dörken B; Daniel PT
    BMC Cancer; 2005 Aug; 5():105. PubMed ID: 16109171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia.
    Dao-Ung LP; Fuller SJ; Sluyter R; SkarRatt KK; Thunberg U; Tobin G; Byth K; Ban M; Rosenquist R; Stewart GJ; Wiley JS
    Br J Haematol; 2004 Jun; 125(6):815-7. PubMed ID: 15180873
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
    Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
    HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23.
    Chen JR; Gu BJ; Dao LP; Bradley CJ; Mulligan SP; Wiley JS
    Br J Haematol; 1999 Apr; 105(1):181-9. PubMed ID: 10233382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5' intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population.
    Skarratt KK; Fuller SJ; Sluyter R; Dao-Ung LP; Gu BJ; Wiley JS
    FEBS Lett; 2005 May; 579(12):2675-8. PubMed ID: 15862308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria.
    Saunders BM; Fernando SL; Sluyter R; Britton WJ; Wiley JS
    J Immunol; 2003 Nov; 171(10):5442-6. PubMed ID: 14607949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.